Healthcare & Biotech

Centennial, Colo. – September 23, 2026 -- AlloSource has named three physicians recipients of its 2026 Dr. Steven Gitelis Inspiration Award, recognizing clinical use of donated human tissue in reconstructive, burn and orthopedic care.

Three physicians recognized for advancing tissue-based medicine

Dr. Victor Stams, a plastic surgeon at Carle Foundation Hospital in Champaign, Illinois, was cited for reconstructive surgery leadership using AlloSource's AlloMend® tissue product. Dr. Sigrid Blome-Eberwein, Associate Director of the Regional Burn Center at Lehigh Valley Hospital Network in Allentown, Pennsylvania, was recognized for treating severe burns with split-thickness skin allografts. Dr. Robert Meislin, a hip specialist at NYU Langone Health, was honored for using AlloSource's pre-sutured fascia product, AceConnex®, in orthopedic mobility restoration.

Chicago – September 23, 2026 -- The Academy of Nutrition and Dietetics, working with the Accreditation Council for Education in Nutrition and Dietetics (ACEND), has launched an initiative to embed evidence-based nutrition training into U.S. medical school curricula, citing rising attention from the U.S. Department of Health and Human Services (HHS) as a catalyst for the effort.

Academy rolls out a microcredential framework to standardize nutrition training

The ACEND Nutrition in Medical Education Microcredential Framework allows accredited nutrition and dietetics programs to convert existing coursework into microlearning units aligned with ACEND curriculum competencies and the HHS Medical Education Nutrition Competency Framework. The tool is designed to give medical schools a structured, program-level path to add nutrition content without building curricula from scratch.

Chicago – September 23, 2026 -- WovenX Health, a Chicago-based specialty care platform, has won the Industry Disrupter Award at 1871's 19th Annual Momentum Awards for its model expanding access to gastroenterology care.

National GI wait times average 40 days as two-thirds of U.S. counties lack a specialist

One in five Americans is affected by a gastrointestinal condition, yet the average wait for a GI consult has grown to 40 days nationally, according to the company. GI-related visits account for 10% of all emergency department visits, 86% of which WovenX says are avoidable with timely specialty access.

Hong Kong – September 23, 2026 -- Ping An Good Doctor (HKEX: 1833) said its AI business accounted for approximately 4.6% of gross profit in the first half of 2026, as the Hong Kong-listed insurer's healthcare arm shifts from diagnostic AI tools toward services that execute care plans on the ground.

Ping An launches AI-powered home rehab coaching

The company upgraded its Ping An AI Doctor service with Ping An Smart Private Coach, a hybrid AI-and-coaching offering that tracks 34 points on the body to deliver real-time feedback across seven categories, including posture correction, chronic-pain rehabilitation, postpartum recovery and Baduanjin qigong exercise. The global market for AI personal trainers is projected to grow from $16.9 billion in 2025 to $65.7 billion by 2033, a trend coinciding with China's National Health Commission "Weight Management Year" initiative launched in 2024.

Boston – September 23, 2026 -- CSA Medical, Inc. announced publication in the American Journal of Respiratory and Critical Care Medicine of pivotal SPRAY-CB trial results showing its RejuvenAir System reduced severe COPD exacerbation rates by 38.4% versus a sham control.

Trial enrolled 210 patients across the US and UK despite optimal medical therapy

The randomized, blinded, sham-controlled SPRAY-CB trial (NCT03893370) tested Metered CryoSpray (MCS) therapy in patients with moderate-to-severe COPD and symptomatic chronic bronchitis who remained highly symptomatic despite receiving standard-of-care medication.

Las Vegas – September 23, 2026 -- Genzeon has been named UiPath's 2026 Industry Impact Partner of the Year for Healthcare and Life Sciences, recognizing five years of joint automation work that has processed hundreds of thousands of healthcare transactions annually.

The award was presented at UiPath FUSION 2026 and cited Genzeon's role in converting AI and robotic process automation into measurable financial and operational outcomes for payers, providers and life sciences clients.

Prior authorization platform handles 450,000 cases annually under CMS mandate

For the CMS WISeR program, Genzeon and UiPath built prior authorization infrastructure processing more than 450,000 cases per year across 17 high-risk service categories. The system automates 85% to 90% of routine determinations while meeting mandatory 72-hour turnaround windows and complying with FHIR and CMS-0057-F requirements.

Aurora, Colo. – September 23, 2026 -- Researchers at the University of Colorado Anschutz report a 100% 24-hour survival rate among 26 Ukrainian military personnel who received drone-delivered freeze-dried plasma at the point of injury, a preliminary finding from an ongoing study testing whether unmanned aircraft can bring blood products to critically injured patients before conventional evacuation reaches them.

Drones carry Octapharma-donated plasma to front-line medics in Ukraine

The freeze-dried plasma, donated by global pharmaceutical company Octapharma, is packaged for transport and flown by drone to medical teams operating near the point of injury. Unlike fresh frozen plasma, which requires freezing and thawing, the freeze-dried version can be stored at room temperature and prepared rapidly for administration, addressing a logistical barrier the FDA has identified for battlefield, remote and disaster settings.

San Diego – September 23, 2026 -- Werfen has secured U.S. FDA 510(k) clearance and a CE Mark under the EU's IVDR for its Aptiva Antiphospholipid Syndrome (APS) IgA Reagent, completing a three-isotype APS testing portfolio on its Aptiva platform.

Aptiva now covers all three APS antibody isotypes for global laboratories

The clearance means Aptiva offers IgA, IgG, and IgM testing for both anti-cardiolipin (aCL) and anti-beta 2 glycoprotein 1 (aβ2GP1) antibodies, giving laboratories a full antibody profile for antiphospholipid syndrome, an autoimmune disease linked to thrombotic events and pregnancy complications that is often difficult to diagnose due to overlapping clinical symptoms.

Provo, Utah – September 23, 2026 -- Qualtrics unveiled Healthcare XM, a new platform built on Press Ganey's proprietary data and what the company calls the world's largest human experiential dataset, aimed at helping health systems and health plans simulate care changes, predict patient behavior, and act on safety risks before they escalate.

Qualtrics builds Healthcare XM on Press Ganey data to close the industry's experience gap

The platform runs on the Qualtrics XM Data & AI Platform and combines decades of Press Ganey benchmarks, regulatory expertise, and predictive analytics. It covers five domains: patient experience across HCAHPS and CAHPS journeys, member experience including Medicare CAHPS and Stars ratings, workforce engagement and retention, safety and quality signals such as NDNQI and PSO data, and consumer and brand positioning.

Quakertown, Pa. – September 23, 2026 -- DEXIS unveiled a coordinated set of upgrades spanning hardware, software, cloud and service offerings across its dental imaging ecosystem, unveiled during the company's ILLUMINATE virtual keynote.

NOMAD Pro 3 upgrades handheld X-ray hardware with improved image quality and durability

The new NOMAD Pro 3 builds on DEXIS' handheld X-ray system, adding enhanced image quality and durability while maintaining safety-first engineering standards. Separately, the ORTHOPANTOMOGRAPH OP 3D gains a Motion Correction feature that reduces the impact of patient movement on CBCT image clarity without requiring hardware changes.